alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 11.01

                 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
<TABLE>
<CAPTION>
                                                                         Period from
                                                                         January 18,
                                                                            1995
                            Three months   Three months   Nine months   (inception)
                                ended          ended         ended          to
                            September 30,     September     September     September
                                1996         30, 1995      30, 1996      30, 1995
                            ------------    ----------    ------------    ---------- 
<S>                         <C>             <C>           <C>             <C>        
Weighted average shares
   and common equivalent
   shares outstanding .....   5,387,924       4,220,659     5,383,962      4,078,745

Adjustment to give effect
   to shares sold
   pursuant to a private
   placement subsequent
   to March 31, 1995 as
   outstanding since
   January 18, 1995,
   using treasury stock
   method .................                     232,784                      351,046

Adjustment to give effect
   to shares issued in
   connection with the
   bridge loans as
   outstanding since
   January 18, 1995,
   using treasury stock
   method .................                      8,750                         8,750

Adjustment to effect to
   the shares optioned to
   key employees,
   directors and
   consultants prior to
   the initial public
   offering as
   outstanding since
   January 18, 1995,
   using the treasury
   stock method ...........                    875,000                       875,000
                            ------------    ----------    ------------    ---------- 
Total                          5,387,924     5,337,193       5,383,962     5,313,541
                            ============    ==========    ============    ========== 
Net Loss                    $ (1,147,432)   $ (554,681)   $ (3,658,233)   $ (658,207)
                            ============    ==========    ============    ========== 
Per-share amount            $      (0.21)   $    (0.10)   $      (0.68)   $    (0.12)
                            ============    ==========    ============    ========== 
</TABLE>
UNITED STATES OF AMERICA

U.S. DEPARTMENT OF HOMELAND SECURITY

UNITED STATES COAST GUARI)

UNITED STATES COAST GUARD,

Complainan(

\s,

JEREMY TRAMAINE TUCKER.

Respondcnt.

Docket Number 2023-0105

CG Enforcement Activity Number 7347946

Br': Honorable Walter J. Brudzinski, Chief Administrative Law Judqe

Apperrances:

CWO WESLEY JOHNSON

USCG Marine Safety Unit Houma

For the Coast Guard

JEREMY TRAMAINE TUCKER, Pro .se

For the Respondent

CONSENT ORDER

Issued: Aoril 26. 2023
UNITED STATES OF AMERICA

U.S. DEPARTMENT OF HOMELAND SECURITY

U\ITED STATES COAST GUARD

JEREMY TRAMAINE TUCKER

Respondent.

Dockct \umber 2023-0 I 05

Enforcement Activitv Number 7347946

CONSENT ORDER APPROVING SETTLEMENT AGREEMENT

On April 25,2023, the parties in this case submitted a Motion for Approval of a

Scttlement Agreement and Entry ofConsent Order to be approved as a settlement of the case

under 33 C.F.R. $ 20.502.

I have carefully reviewed the terms of the Settlement Agreement and find that it is fair,

reasonable, and in substantial compliancc with thc requirements of33 C.F.R. S 20.502.

ORDER

Upon consideration of the record, it is hereby ORDERED, the Settlcmcnt Agrecmcnt is

APPROVED in full and incorporated herein by refercncc. This Consent Order shall constitute

full, final, and complete adjudication of this proceeding.

Done and dated April 26,2023

New York, NY

ys.

ue,/ s4.{*A

HON. WALTER J. BRUDZINSKI

CHIEF ADMINISTRATIVE LAW JUDGE

UNITED STATES COAST GUARD

2

UNITED STATES COAST GUARD

Complainant,
[Federal Register Volume 86, Number 179 (Monday, September 20, 2021)]
[Notices]
[Page 52131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20417]


=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

TIME AND DATE: 10:00 a.m. EDT, Thursday, September 30, 2021.

PLACE: Virtual meeting.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Enforcement matters. In the event that the 
time, date, or location of this meeting changes, an announcement of the 
change, along with the new time, date, and/or place of the meeting will 
be posted on the Commission's website at https://www.cftc.gov/.

CONTACT PERSON FOR MORE INFORMATION: Christopher Kirkpatrick, 202-418-
5964.

    Authority: 5 U.S.C. 552b.

    Dated: September 16, 2021.
Christopher Kirkpatrick,
Secretary of the Commission.
[FR Doc. 2021-20417 Filed 9-16-21; 4:15 pm]
BILLING CODE 6351-01-P
ANIMAS RIVER AT TALL TIMBER RESORT NEAR ROCKWOODLatitude: 37.597Longitude: -107.777Elevation: 7682

ANIMAS RIVER AT TALL TIMBER RESORT NEAR ROCKWOOD

Courtesy NRCS - Go to Beartown Site Page...



Beartown

Courtesy NRCS - Go to Cascade Site Page...



Cascade

Courtesy NRCS - Go to Cascade #2 Site Page...



Cascade #2

Courtesy NRCS - Go to Idarado Site Page...



Idarado

Courtesy NRCS - Go to Mineral Creek Site Page...



Mineral Creek

Courtesy NRCS - Go to Molas Lake Site Page...



Molas Lake

Courtesy NRCS - Go to Red Mountain Pass Site Page...



Red Mountain Pass

Courtesy NRCS - Go to Spud Mountain Site Page...



Spud Mountain
MEDIA ADVISORY Contact: Angelia Rorison

February 9, 2024 publicaffairs@usccr.gov

U.S. Commission on Civil Rights Releases Translated 2023 

Statutory Enforcement Report, The Federal Response to AntiAsian Racism in the United States

WASHINGTON, D.C. -- Today, the United States Commission on Civil Rights (Commission) 

takes a significant step towards increasing accessibility for the Asian American community by 

releasing translated materials for its 2023 statutory enforcement report. The report, " The 

Federal Response to Anti-Asian Racism in the United States" provides comprehensive insights 

on the rise of anti-Asian hate crimes from 2019 through 2021 and the federal role in preventing 

and enforcing federal hate crime laws. 

The report's press release, letter of transmittal, and executive summary are now available in the 

top five Asian languages spoken at home in the U.S. according to the 2019 Census. These 

translated materials include Mandarin (Chinese Simplified), Cantonese (Chinese Traditional), 

and Vietnamese versions of the press release, letter of transmittal, and executive summary.

• Mandarin (Chinese Simplified) 

o Press Release

o Letter of Transmittal

o Executive Summary

• Cantonese (Chinese Traditional)

o Press Release

o Letter of Transmittal

o Executive Summary

• Vietnamese

o Press Release

o Letter of Transmittal 

o Executive Summary

According to Commission Chair, Rochelle Mercedes Garza, "Language accessibility is critical for 

communicating with impacted communities. We know that language barriers prevent the 

reporting of hate crimes or incidents, such as racial slurs or being spat on. The translation of 

these materials shows the Commission's commitment to increasing accessibility for the Asian 

American community."

Additionally, the report's key recommendation aligns with the Commission's release on 

November 15, 2023, of an updated federal agency language access plan, coinciding with the oneyear anniversary of Attorney General Merrick B. Garland's language access memorandum to 

federal agencies.

The updated language access plan showcases the Commission's dedication to providing more 

reports and agency events with appropriate language access through translation and 

interpretation services.

###

The U.S. Commission on Civil Rights, established by the Civil Rights Act of 1957, is the only independent, bipartisan

agency charged with advising the President and Congress on civil rights and reporting annually on federal civil rights

enforcement. Our 56 state Advisory Committees offer a broad perspective on civil rights concerns at state and local

levels. The Commission: in our 7th decade, a continuing legacy of influence in civil rights. For information about the

Commission, please visit www.usccr.gov and on Twitter and Facebook.

• Tagalog (Filipino) 

o Press Release

o Letter of Transmittal

o Executive Summary

• Korean

o Press Release

o Letter of Transmittal

o Executive Summary
# C_2021307EN.01001101.xml

| 30.7.2021 | EN | Official Journal of the European Union | C 307/11 |
| --- | --- | --- | --- |

30.7.2021

EN

Official Journal of the European Union

C 307/11

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2021 to 30 June 2021

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))

(2021/C 307/02)

| — | Issuing, maintenance or modification of a national marketing authorisation |
| --- | --- |

—

Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | INN (International Non-Proprietary Name) | Holder(s) of the marketing authorisation | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- | --- |
| 21.6.2021 | ifosfamide-containing solutions | ifosfamide-containing solutions | See Annex | See Annex | 22.6.2021 |

Date of the decision

Name(s) of the medicinal product

INN (International Non-Proprietary Name)

Holder(s) of the marketing authorisation

Member State concerned

Date of notification

21.6.2021

ifosfamide-containing solutions

ifosfamide-containing solutions

See Annex

See Annex

22.6.2021

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX

List of medicinal products and presentations

| Member State
  EU/EEA | Marketing authorisation holder | Invented name | INN + Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| France | Eg Labo Laboratoires Eurogenerics | Ifosfamide Eg | Ifosfamide 40 mg/ml | Solution for infusion | Intravenous use |
| Germany | Stadapharm GmbH | Ifo-Cell | Ifosfamide 200 mg/ml | Concentrate for solution for infusion | Intravenous use |
| Germany | Stadapharm GmbH | Ifo-Cell N | Ifosfamide 40 mg/ml | Solution for infusion | Intravenous use |
| Germany | Stadapharm GmbH | Ifo-Cell N 2000 | Ifosfamide 40 mg/ml | Solution for infusion | Intravenous use |

Member State

EU/EEA

Marketing authorisation holder

Invented name

INN + Strength

Pharmaceutical form

Route of administration

France

Eg Labo Laboratoires Eurogenerics

Ifosfamide Eg

Ifosfamide 40 mg/ml

Solution for infusion

Intravenous use

Germany

Stadapharm GmbH

Ifo-Cell

Ifosfamide 200 mg/ml

Concentrate for solution for infusion

Intravenous use

Germany

Stadapharm GmbH

Ifo-Cell N

Ifosfamide 40 mg/ml

Solution for infusion

Intravenous use

Germany

Stadapharm GmbH

Ifo-Cell N 2000

Ifosfamide 40 mg/ml

Solution for infusion

Intravenous use

---
Fourth Court of Appeals

San Antonio, Texas

July 10, 2019

No. 04-19-00445-CV

IN RE Jason D. PRESLEY

Original Mandamus Proceeding1

ORDER

On July 1, 2019, relator filed a petition for writ of mandamus and a motion for temporary 

relief pending final resolution of the petition for writ of mandamus. After considering the petition, 

this court concludes relator is not entitled to the relief sought. Accordingly, the petition for writ 

of mandamus is DENIED. See TEX. R. APP. P. 52.8(a). The motion for temporary relief is 

DENIED AS MOOT.

It is so ORDERED on July 10, 2019.

_____________________________

Beth Watkins, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 10th day of July, 2019.

_____________________________

Keith E. Hottle, Clerk of Court

 1 This proceeding arises out of Cause No. 2018CI01770, styled In the Matter of the Marriage of Jason Dale Presley 

and Suzanne Marie Presley and In the Interest of Z.B.P. and V.I.P., Children, pending in the 224th Judicial District 

Court, Bexar County, Texas, the Honorable Angelica Jimenez presiding.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK> 0001018753
<NAME> LAKEWAY CLUBS, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1996
<PERIOD-START>                             OCT-01-1995
<PERIOD-END>                               SEP-30-1996
<CASH>                                          14,915
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                14,915
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   1,000
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                     1,000
<SALES>                                         51,910
<TOTAL-REVENUES>                                51,910
<CGS>                                           51,910
<TOTAL-COSTS>                                   51,910
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
# C_2021291EN.01000101.xml

| 21.7.2021 | EN | Official Journal of the European Union | C 291/1 |
| --- | --- | --- | --- |

21.7.2021

EN

Official Journal of the European Union

C 291/1

---

Non-opposition to a notified concentration

(Case M.10300 — TIAA/AP1/AP2/GPIF/Courbevoie)

(Text with EEA relevance)

(2021/C 291/01)

On 15 July 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10300. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10300. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
<PAGE>
 
                                                                    EXHIBIT 10.8

                      [ALLEGIANCE CORPORATION LETTERHEAD]


October 16, 1996


Bank of America National Trust
  and Savings Association, as
  Administrative Agent for the
  Banks parties to the Credit
  Agreement referred to below
1455 Market Street, 12th Floor
San Francisco, California  94103
Attention:  Agency Administrative Services
            Unit #5596

Reference:  The $1.2 billion Credit Agreement (Facility A) (the "Credit
            Agreement") dated as of September 23, 1996 among Allegiance
            Corporation, as Borrower, and Bank of America National Trust and
            Savings Association, as Administrative Agent and other financial
            institutions that are parties to this Credit Agreement

Ladies and Gentlemen:

The undersigned, Allegiance Corporation, refers to the above mentioned "Credit
Agreement", (the terms defined therein being used herein as therein defined),
and hereby gives you notice pursuant to Section 4.05 of the Agreement that the
undersigned requests a reduction of the Commitments in the aggregate amount of
$300 million effective October 23, 1996.  After giving effect to such reduction,
the aggregate commitments will be $900 million.

If you have any questions concerning this matter, please call me at 847-578-
4420.

Very truly yours,

ALLEGIANCE CORPORATION

By:  /s/ Leonard G. Kuhr
     -------------------------------------
     Corporate Vice President & Treasurer

cc:  William Sweeney, BankAmerica

45094\021\10EX10-8.001
<PAGE>   1
                                                                    EXHIBIT 10.3



                                 PROMISSORY NOTE


                                                          Waltham, Massachusetts
                                                               December 31, 1998

$150,000

     FOR VALUE RECEIVED, the undersigned, Dr. Douglas Reed (the "Borrower"),
hereby promises to pay to the order of GelTex Pharmaceuticals, Inc., a Delaware
corporation (the "Lender") the principal amount of One Hundred Fifty Thousand
and 00/100 Dollars ($150,000) (the "Principal") on or before the Maturity Date,
as hereinafter defined. This Note is given as evidence of a loan in an amount
equal to the principal amount of this Note. The purpose of the loan is to assist
the Borrower in financing the purchase of his new principal residence located at
90 Ruddock Road, Sudbury, Massachusetts.

     Interest shall not accrue on the outstanding Principal during the term of
this Note, unless Dr. Reed's employment with the Lender is terminated for
whatever reason prior to the Maturity Date. Upon Dr. Reed's termination,
interest shall accrue as of the date of such termination in an amount equal to
the Prime Rate of interest, as in effect from time to time (but in no event in
excess of the maximum rate permitted by then applicable law) as announced by
Fleet National Bank. Any accrued interest shall be due and payable on the
Maturity Date.

     The Maturity Date of this Note shall be the earlier of (i) fifteen days
following the closing date of the Borrower's sale of the property located at
3021 E. Thackeray Place, Salt Lake City, Utah or (ii) June 30, 1999.

     The Borrower hereby agrees to pay, to the extent permitted by law, all
reasonable costs and expenses, including, without limitation, reasonable
attorneys' fees, incurred or paid by the Lender in enforcing this note, whether
or not litigation is commenced.

     If any provisions hereof or the application thereof to any person or
circumstance shall, to any extent, be invalid or unenforceable, the remainder
hereof, or the application of such provision to persons or circumstances other
than those as to which it is held invalid or unenforceable, shall not be
affected thereby, and each provision hereof shall be valid and in force to the
fullest extent permitted by law.


<PAGE>   2


     This Note shall be governed by and construed in accordance with the laws of
the Commonwealth of Massachusetts, and shall take effect as a sealed instrument.

     Executed as of the day and year first written above.



/s/ Douglas Reed
----------------------------------
Douglas Reed

WITNESS:

/s/ Elizabeth Grammer
----------------------------------

Elizabeth Grammer
----------------------------------
Print Name
# C_2021311EN.01000501.xml

| 3.8.2021 | EN | Official Journal of the European Union | C 311/5 |
| --- | --- | --- | --- |

3.8.2021

EN

Official Journal of the European Union

C 311/5

---

Notice of the impending expiry of certain anti-dumping measures

(2021/C 311/05)

1.   As provided for in Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (1), the Commission gives notice that, unless a review is initiated in accordance with the following procedure, the anti-dumping measures mentioned below will expire on the date mentioned in the table below.

2.   Procedure

Union producers may submit a written request for a review. This request must contain sufficient evidence that the expiry of the measures would be likely to result in a continuation or recurrence of dumping and injury. Should the Commission decide to review the measures concerned, importers, exporters, representatives of the exporting country and Union producers will then be provided with the opportunity to amplify, rebut or comment on the matters set out in the review request.

3.   Time limit

Union producers may submit a written request for a review on the above basis, to reach the European Commission, Directorate-General for Trade (Unit G-1), CHAR 4/39, 1049 Brussels, Belgium (2) at any time from the date of the publication of the present notice but no later than three months before the date mentioned in the table below.

4.   This notice is published in accordance with Article 11(2) of Regulation (EU) 2016/1036.

| Product | Country(ies) of origin or exportation | Measures | Reference | Date of expiry (3) |
| --- | --- | --- | --- | --- |
| Certain continuous filament glass fibre products | The People’s Republic of China | Anti-dumping duty | Commission Implementing Regulation (EU) 2017/724 of 24 April 2017 imposing a definitive anti-dumping duty on imports of certain continuous filament glass fibre products originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council
  (OJ L 107, 25.4.2017, p. 4) | 26.4.2022 |

Product

Country(ies) of origin or exportation

Measures

Reference

Date of expiry (3)

Certain continuous filament glass fibre products

The People’s Republic of China

Anti-dumping duty

Commission Implementing Regulation (EU) 2017/724 of 24 April 2017 imposing a definitive anti-dumping duty on imports of certain continuous filament glass fibre products originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council

(OJ L 107, 25.4.2017, p. 4)

26.4.2022

---

(1)  OJ L 176, 30.6.2016, p. 21.

(2)  TRADE-Defence-Complaints@ec.europa.eu

(3)  The measure expires at midnight (00:00) of the day mentioned in this column.

---